Celanese Showcases Medical Polymers at Pharmapack 2017

DALLAS & PARIS--()--Celanese Corporation (NYSE: CE), a global technology and specialty materials company, will showcase one of the broadest medical polymer product portfolios in the industry at the 2017 Drug Delivery & Packaging Pharmapack event at the Paris Expo Porte de Versailles in Paris, France.

At Pharmapack, Celanese will also introduce medical device researchers and manufacturers to the Celanese MT® (Medical Technology) grade of polymers used to design products capable of moving parts, precision dosing and wear resistance. Celanese materials have supported diverse customer applications and platforms including orthopedic implants, insulin injection pens, asthma inhalers, syringes and surgical staple cartridges.

“Celanese has been supporting our customers’ growth in medical devices and platforms for decades. We continue to provide a broad materials portfolio covering a wide range of chemical resistance, mechanical performance and usage temperatures,” said Isaac Khalil, vice president of Celanese’s Global Medical business. “Celanese also has the ability to customize materials to meet our customers’ specific CTQs, and our technical teams can provide computer-aided engineering services to support part design and processing across our customers’ manufacturing ecosystem. We look forward to showcasing Celanese’s MT® portfolio, technical engagement model and services at Pharmapack 2017.”

Celanese will also offer a Learning Lab Presentation at Pharmapack to discuss its unique medical device materials:

Topic:

   

Vectra® LCP – A Unique Material for Medical Devices

Date/Time:

Thursday, February 2nd at 10:10-10:40 a.m. local time

Presenter:

Wendy Johnson, Customer & Application Marketing Manager, Medical

Celanese medical polymer experts will be meeting with Pharmapack attendees at Booth C80 in Hall 4 at the Paris expo Porte de Versailles February 1-2. For more information about Celanese’s medical and pharmaceutical materials solutions, visit http://healthcare.celanese.com/.

About Celanese

Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. Our two complementary business cores, Acetyl Chain and Materials Solutions, use the full breadth of Celanese’s global chemistry, technology and business expertise to create value for our customers and the corporation. As we partner with our customers to solve their most critical business needs, we strive to make a positive impact on our communities and the world through The Celanese Foundation. Based in Dallas, Celanese employs approximately 7,000 employees worldwide and had 2015 net sales of $5.7 billion. For more information about Celanese and our product offerings, visit www.celanese.com or our blog at www.celaneseblog.com.

All registered trademarks are owned by Celanese International Corporation or its affiliates.

Forward-Looking Statements

This release may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this release, the words “outlook,” “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company or its customers will realize these benefits or that these expectations will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Other risk factors include those that are discussed in the company’s filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

Contacts

Celanese Corporation
Investor Relations
Surabhi Varshney, +1-972-443-3078
surabhi.varshney@celanese.com
or
Media Relations – Global
W. Travis Jacobsen, +1-972-443-3750
william.jacobsen@celanese.com
or
Media Relations Asia (Shanghai)
Helen Zhang, +86 21 3861 9279
lan.zhang@celanese.com
or
Media Relations Europe (Germany)
Jens Kurth, +49(0)69 45009 1574
j.kurth@celanese.com

Release Summary

Celanese Showcases Medical Polymers at Pharmapack 2017

#Hashtags

$Cashtags

Contacts

Celanese Corporation
Investor Relations
Surabhi Varshney, +1-972-443-3078
surabhi.varshney@celanese.com
or
Media Relations – Global
W. Travis Jacobsen, +1-972-443-3750
william.jacobsen@celanese.com
or
Media Relations Asia (Shanghai)
Helen Zhang, +86 21 3861 9279
lan.zhang@celanese.com
or
Media Relations Europe (Germany)
Jens Kurth, +49(0)69 45009 1574
j.kurth@celanese.com